TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 9,930.00
-60.00 (-0.60%)
At close: May 15, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 299.37 billion as of May 15, 2026. Its market cap has increased by 241.16% in one year.
Market Cap
299.37B
Enterprise Value
300.33B
Revenue
12.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,930.00
Market Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 299.37B, a decrease of -4.02%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 302.06B | 77.07% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 500.23B |
| HansBiomed | 397.89B |
| S.Biomedics | 387.04B |
| curacle co.,ltd. | 322.76B |
| Y-Biologics | 320.26B |
| Kangstem Biotech | 309.91B |
| NIBEC | 258.62B |
| Bio Solution | 247.72B |